List of Studies
The table below shows the current NIMH studies, both released and in-process. For in-process studies that are not yet released for distribution, the table shows the expected number of subjects, marked with an orange superscript.
Study | Title | Distributions | PIs | Grants | Sites | Subjects |
---|---|---|---|---|---|---|
0 | NIMH Bipolar Genetics Initiative | Bipolar Disorder | DEPAULO, MCMAHON, NURNBERGER, REICH |
5U01MH046282, 5U01MH046280, 5U01MH046274 |
10, 12 | 1353 |
0 | NIMH Schizophrenia Genetics Initiative | Schizophrenia | CLONINGER, KAUFMANN, TSUANG |
5U01MH046318, 5U01MH046276, 5U01MH046289 |
30, 31, 32 | 877 |
0 | NIMH Alzheimers Genetics Initiative | Alzheimer's Disease | ALBERT, BASSETT, GO |
5U01MH046281, 5U01MH046290, 5U01MH046373 |
50, 51, 52 | 1411 |
1 | A Collaborative Genomic Study of Bipolar Disorder | Bipolar Disorder | BERRETTINI, BYERLEY, CORYELL, DEPAULO, MCMAHON, NURNBERGER | 20, 21, 22, 23, 24, 25, 26, 28, 29 | 1880 | |
2 | Molecular Genetics of Bipolar Disorder | Bipolar Disorder | BARON | 15, 16 | 843 | |
3 | Genetic Linkage Study of Schizophrenia | Schizophrenia | TSUANG | 34, 35 | 2328 | |
4 | Collaborative Linkage Study of Autism | Autism | FOLSTEIN, PIVEN | 60, 61, 89 | 652 | |
6 | Molecular Genetics of Schizophrenia | Induced Pluripotent Stem Cells, Schizophrenia | BYERLEY, CLONINGER, GEJMAN | 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 | 1384 | |
7 | Genetics of Early-Onset Major Depression | Depression | DEPAULO, WEISSMAN, ZUBENKO | 80, 81, 82, 83, 84, 85 | 2238 | |
8 | Genetic Analysis of Bipolar Disorder | Bipolar Disorder | PATO | 38 | 223 | |
9 | A study of Schizophrenia | Schizophrenia | BERMAN, WEINBERGER |
NA |
39 | 830 |
10 | Collaborative Linkage Study in Autism | Autism | FOLSTEIN | 62 | 4 | |
12 | Genetic Analysis of Psychosis | Schizophrenia | PATO | 33 | 233 | |
13 | Genetics of Schizophrenia in Latino Populations | Schizophrenia | ALMASY, CANIVE, ESCAMILLA, GLAHN, NICOLINI, RAVENTOS | 17, 53, 54, 55, 56, 57, 58, 59 | 1241 | |
14 | Molecular Genetics of Infantile Autism | Autism | RISCH | 63 | 563 | |
15 | A Neurobehavioral Family Study of Schizophrenia | Schizophrenia | NIMGAONKAR | 70, 71 | 645 | |
16 | Collaborative OCD Genetic Study | Obsessive-Compulsive Disorder | NESTADT | 164, 64, 65, 66, 67, 68, 69 | 1351 | |
17 | CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES (CATIE); Replication of Schizophrenia Associations in CATIE | Alzheimer's Disease, Schizophrenia | LIEBERMAN, SULLIVAN |
N01MH090001,
R01MH074027
|
75, 76 | 926 |
18 | Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | Depression | RUSH |
N01MH090003
|
77 | 1942 |
19 | Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) | Bipolar Disorder, Controls | NIMGAONKAR |
N01MH080001
|
14, 78, 86, 88 | 2365 |
20 | Treatment of Adolescents with Depression (TADS) | Depression | MARCH |
contract RFP-NIH-NIMH 98-DS-0008
|
79 | 171 |
21 | AGRE; A Genomewide Search for Autism Susceptibility Loci | Autism | GESCHWIND | 72, 74 | 3909 | |
22 | Project among African-Americans to explore risks for schizophrenia (PAARTNERS) | Schizophrenia | GO, NIMGAONKAR | 101, 102, 103, 104, 105, 106, 107, 108, 109 | 1739 | |
23 | Genetic Susceptibility in Schizophrenia | Controls, Schizophrenia | NIMGAONKAR | 73 | 489 | |
24 | Genetics of Anorexia Nervosa | Eating Disorders | BERRETTINI, HALMI, KAYE | 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120 | 1208 | |
25 | International Multi-Center ADHD Genetics Project (IMAGE) | Attention-Deficit Hyperactivity Disorder | FARAONE | 19, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 | 4959 | |
27 | The Genetics of Endophenotypes and Schizophrenia (COGS) | Schizophrenia | BRAFF | 122, 123, 124, 125, 126, 127, 128, 253, 254, 255, 256, 257 | 1347 | |
28 | A study of ADHD (CHOP) | Attention-Deficit Hyperactivity Disorder | ELIA | 130 | 1500 | |
29 | Molecular Genetics of Schizophrenia | Controls, Induced Pluripotent Stem Cells, Schizophrenia | BYERLEY, GEJMAN | 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150 | 9011 | |
30 | A study of Autism | Autism | RODIER |
1P50HD055753-01,
5U19HD035466-08
|
158 | 50 |
31 | A study of Autism | Autism | RODIER |
1P50HD055753-01,
5U19HD035466-08
|
151 | 79 |
32 | A study of Autism | Autism | SZATMARI |
|
152 | 483 |
33 | Longitudinal Study of Language and Theory of Mind in Autism | Autism | TAGER-FLUSBERG |
P01DC003610, 3U19DC003610-08S1 |
153 | 210 |
34 | Neurobiology and Genetics of Autism | Autism | DAWSON |
U19HD035465
|
154 | 214 |
35 | Molecular and Genetic Epidemiology of Autism | Autism | PERICAK-VANCE | 155 | 1221 | |
36 | A study of Autism | Autism | MCINNES |
|
156 | 310 |
37 | Research Units of Pediatric Psychopharmacology (RUPP-PI) | Autism | MCDOUGLE |
U10MH066766
|
157 | 133 |
39 | New Jersey Language & Autism Genetics Study (NJLAGS) | Autism | BRZUSTOWICZ | 161 | 648 | |
40 | Bipolar Genome Study (BiGS) | Bipolar Disorder | BERRETTINI, BYERLEY, CORYELL, MCINNIS, NURNBERGER |
P50CA89392, K02DA021237 |
170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181 | 3934 |
41 | The Development of the Siblings of Children with Autism: A Longitudinal Study; Heterogeneity in Autism Biomarkers, Trajectories and Treatments | Autism | BOOKHEIMER, GESCHWIND |
P50HD055784
|
700, 701, 702, 703, 704, 706, 707 | 438 |
42 | A Genome Wide SNP Association Study: Schizophrenia | Schizophrenia | FALLIN, PULVER | 185 | 197 | |
43 | A study of ADHD | Attention-Deficit Hyperactivity Disorder | TODD, TODOROV |
|
132 | 800 |
44 | Genetic Analysis of 15q11-q13 in Autism | Autism | SUTCLIFFE | 165 | 362 | |
45 | Detection of Susceptibility Genes in ADHD | Attention-Deficit Hyperactivity Disorder | LOO | 135 | 1200 | |
48 | Genetic Linkage and Association in Bipolar Disorder / Amish Mennonite Bipolar Genetics Study (AmBiGen) | Bipolar Disorder | DEPAULO, MCMAHON |
PART1: Application Number NA_00038551 (JH IRB #) / PART 2: ZIA MH002843-11 DIRP |
186, 187, 188 | 471 |
49 | Genetics of Bipolar Disorder in Latino Populations | Bipolar Disorder | ALMASY, ESCAMILLA, GLAHN, RAVENTOS | 190, 191, 192, 193, 194, 195, 196, 197 | 2679 | |
50 | Genetics of Autism Intermediate Phenotypes | Autism | COON | 200, 201 | 1778 | |
51 | A study of ADHD | Attention-Deficit Hyperactivity Disorder | MARTIN, TODD, TODOROV |
5R01MH071629-02 |
121 | 1700 |
52 | Genetics of Early-Onset Major Depression (GenRED II) | Depression | CORYELL, DEPAULO, WEISSMAN | 280, 281, 282, 283, 284, 285, 286 | 1902 | |
55 | Adolescents at High Risk for Familial Bipolar Disorder | Bipolar Disorder | MCINNIS, NURNBERGER | 750, 751, 752, 753 | 325 | |
56 | Clinical and Immunological Investigations of Subtypes of Autism | Autism | AMARAL, ROGERS, THURM, VAN DE WATER |
Clinical and Immunological Investigations of Subtypes of Autism |
163, 208 | 1188 |
58 | Genetics of Brain Structure and Function | Brain Function | BLANGERO, GLAHN | 136 | 1480 | |
59 | High-Density Genome-Wide Association Study of Schizophrenia in Large Dutch Sample | Schizophrenia | OPHOFF | 100 | 331 | |
60 | A study of Autism | Autism | PIVEN |
|
167 | 276 |
61 | Molecular Genetic Studies of Human Anxiety Disorder | Fear & Anxiety | HEN | 137 | 380 | |
62 | Molecular Genetic Studies of Human Anxiety Disorder | Fear & Anxiety | FYER | 138 | 197 | |
63 | Interdisciplinary Studies of Insistence on Sameness in Autism Spectrum Disorders | Autism | COOK |
P50HD055751
|
168 | 515 |
64 | Center for Genomic and Phenomic Studies in Autism | Autism | LAJONCHERE, ROULLET, SOHL |
5U24MH081810,
R01MH081754
|
202, 203, 204, 205, 206, 207, 229 | 1263 |
65 | Trio Autism Simplex Collection (TASC) | Autism | GESCHWIND, NURNBERGER, SZATMARI |
Funded by Autism Speaks
|
210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221 | 3384 |
66 | OCD Collaborative Genetics Association Study | Obsessive-Compulsive Disorder | FYER, NESTADT | 240, 241, 242, 243, 244 | 3419 | |
67 | Population Based Mapping of Schizophrenia Genes | Schizophrenia | ESCAMILLA, RAVENTOS | 129 | 523 | |
68 | Biological Prediction of Psychosis Susceptibility among Adolescent Cannabis Users | Schizophrenia | DELISI | 131, 18 | 73 | |
69 | Biological and Information Processing Mechanisms Underlying Autism | Autism | MINSHEW |
P50HD055748
|
209 | 263 |
70 | Consortium for Neuropsychiatric Phenomics | Research Domain Criteria | BILDER |
1UL1RR024911
|
182 | 1096 |
71 | Bipolar Endophenotypes in Population Isolates | Bipolar Disorder | FREIMER | 198, 199 | 546 | |
72 | Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE) | Schizophrenia | KOPELOWICZ, MANSCHRECK, MILLER |
U01MH070010
|
261 | 186 |
73 | Combining Medications to Enhance Depression Outcomes (CO-MED) | Depression | KORNSTEIN, LEUCHTER, PRESKORN, ZISOOK |
N01 MH090003-02
|
287 | 478 |
74 | Examination of Genetic and GxE Effects in the Family and Community Health Studies (FACHS) | Depression | PHILIBERT | 133, 134 | 800 | |
75 | Lithium Use for Bipolar Disorder: A Randomized Controlled Effectiveness Trial (LiTMUS) | Bipolar Disorder | IOSIFESCU, OSTACHER, THASE |
Lithium Use for Bipolar Disorder: A Randomized Controlled Effectiveness Trial
|
189 | 192 |
76 | Genomic Psychiatry Cohort (GPC) | Controls, Schizophrenia | BROMET, ESCAMILLA, MALASPINA, PATO | 251, 262, 263, 264, 265, 266, 267, 268, 269, 271, 351, 352, 844, 869 | 20292 | |
77 | International Cohort Collection for Bipolar Disorder | Bipolar Disorder, Controls | BROMET, ESCAMILLA, MALASPINA, SMOLLER | 252, 270, 272, 273, 274, 275, 304, 305, 306, 307, 308, 309, 310, 311, 312, 845, 868 | 9377 | |
78 | Netherlands Twin Register | Netherlands Twin Register | BARTELS, BOOMSMA, DE GEUS |
R01D0042157-01A |
169 | 8540 |
79 | AUTISM GENETICS: HOMOZYGOSITY MAPPING AND FUNCTIONAL VALIDATION | Autism | DEMMER, KUNKEL, WALSH |
R01MH085143,
R01MH083565
|
222, 223, 224, 225, 226, 227 | 1064 |
80 | Suicidal Behavior in Mood Disorders: Genes and Intermediate Phenotypes | Suicide | MANN, RUJESCU, TURECKI | 288, 289, 290 | 181 | |
81 | Predictors and Mechanisms of Conversion to Psychosis (NAPLS) | Schizophrenia | ADDINGTON, CORNBLATT |
R01MH082004
|
291, 292, 293, 294, 295, 296, 297, 298 | 960 |
82 | Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan | Schizophrenia | GLATT, TSUANG | 183 | 9083 | |
83 | Incomplete Response in Late Life Depression: Getting to Remission | Depression | MULSANT, TSUANG | 277, 278, 279 | 437 | |
84 | Predictors of Antidepressant Treatment Response: The Emory CIDAR; Predictors of Treatment Response, Relaps, and Recurrence in Major Depression | Depression | CRAIGHEAD, MAYBERG | 276 | 231 | |
85 | Language and Risk in Schizophrenia | Schizophrenia | DELISI | 260 | 90 | |
86 | Autism-Spectrum Disorder Genetics | Autism | HAINES, PERICAK-VANCE | 230 | 200 | |
87 | Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative | Post-traumatic Stress Disorder | MAYBERG | 299, 300, 313, 314 | 108 | |
88 | Depression Susceptibility Genes and Networks: Expression, eQTL and GWAS Analysis | Depression | LEVINSON | 621 | 463 | |
90 | A genome-wide association study of Schizophrenia in Ireland | Schizophrenia | CORVIN, RILEY | 301, 302 | 562 | |
91 | Whole-genome sequencing for rare highly penetrant gene variants in schizophrenia | Schizophrenia | GOLDSTEIN | 258, 259 | 226 | |
92 | Family-Based Genome-Wide Methylation Scan in Neurocognition and Schizophrenia | Induced Pluripotent Stem Cells | GUR, NIMGAONKAR | 320, 321, 322, 323 | 130 | |
93 | Identifying Intermediate Phenotypes for Compulsive Hoarding | Obsessive-Compulsive Disorder | MATHEWS | 245 | 120 | |
94 | Common and rare variant genetic screens for clozopine-induced agranulocytosis (CIAC) | Schizophrenia | SULLIVAN | 324, 325, 326 | 270 | |
95 | Abnormal Sterols in ASD and NIMH HGI Repository Expansion (4000) | Autism | TIERNEY |
RC2MH090027 |
232, 233, 234 | 400 |
96 | Olanzapine Versus Placebo in Outpatients with Anorexia Nervosa | Eating Disorders | ATTIA, STEINGLASS | 395, 396, 397, 398, 399 | 73 | |
98 | The Effects of Estradiol on Genetic Risk for Disordered Eating during Puberty | Eating Disorders | KLUMP | 246 | 362 | |
99 | Brain-Behavior and Genetic Studies of the 22q11DS | 22Q11.2DS | GUR | 247, 248 | 358 | |
100 | A Longitudinal Imaging Study of Infants at Risk for Autism | Autism | BOTTERON, PIVEN |
R01HD055741
|
236, 237, 238, 239 | 0 |
101 | Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder | Induced Pluripotent Stem Cells | BERRETTINI, CORYELL, KELSOE, LOHOFF, MCINNIS, NIEVERGELT, NURNBERGER, ODEGAARD |
U01MH092758
|
420, 421, 422, 423, 424, 425, 426, 427, 428, 429 | 700 |
102 | Genomic Studies of Bipolar Disorder in a Large Cohort from the Netherlands | Bipolar Disorder | OPHOFF | 430, 431 | 2500 | |
103 | Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression | Depression | FAVA, MATHEW, SANACORA, ZARATE | 622, 623, 624, 625 | 275 | |
104 | Comparison of Long-Acting Injectable Medications for Schizophrenia (ACLAIMS) | Schizophrenia | BYERLEY, CAROFF, JARSKOG, KONICKI, LAMBERTI, STROUP |
R01MH081107
|
327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347 | 174 |
105 | Establishing Moderators/Biosignatures of Antidepressant Response- Clinical Care (EMBARC) | Depression | MCGRATH, TRIVEDI, WEISSMAN |
U01MH092221,
U01MH092250
|
626, 627, 628, 629 | 400 |
106 | Collaborative Genomic Studies of Tourette Disorder | Tourette Syndrome | BROWN, COFFEY, GILBERT, GRICE, HEIMAN, KUPERMAN, STATE, TISCHFIELD, ZINNER |
R01MH092293
|
600, 602, 603, 604, 605, 606, 607, 608, 609, 610, 611, 612, 613, 614, 615, 616, 617, 618, 619, 620 | 3043 |
107 | RAISE - Early Treatment Program (ETP) Genetics | Schizophrenia | KANE |
HHSN-271-2009-00019C
|
350 | 400 |
108 | Sustaining Remission of Psychotic Depression | Depression | FLINT, MEYERS, ROTHSCHILD, WHYTE | 630, 631, 632, 633 | 177 | |
109 | Discovery Science of Human Brain Function Across the Lifespan | Brain Function | MILHAM | 303 | 331 | |
110 | D-Cycloserine Augmentation of CBT for Pediatric OCD | Obsessive-Compulsive Disorder | GELLER, STORCH |
R01MH093402,
R01MH093381
|
249, 250 | 116 |
111 | Biomarkers for Psychosis in Velo-cardio-facial Syndrome | 22Q11.2DS | KATES | 394 | 64 | |
112 | The Genetics of Autism: Epilepsy as a Biomarker | Autism | DEVINSKY |
The Genetics of Autism: Epilepsy as a Biomarker |
724, 725, 740 | 388 |
113 | Identifying Biomarkers for Post-Partum Depression in African-American Women | Depression | RUBINOW, SULLIVAN | 634 | 2000 | |
114 | Mapping the Human Connectome: Structure, Function, and Heritability | Brain Function | VAN ESSEN |
U54MH091657
|
400 | 1209 |
115 | Exploring the Neuronal Phenotype of Autism Spectrum Disorders Using Induced Pluri | Induced Pluripotent Stem Cells, Phelan-McDermid Syndrome | DOLMETSCH, HALLMAYER | 726, 734 | 188 | |
116 | Cellular and genetic correlates of increased head size in autism spectrum disorder | Autism, Induced Pluripotent Stem Cells | VACCARINO |
R33MH087879
|
727 | 74 |
117 | Autism iPSCs for Studying Function and Dysfunction in Human Neural Development | Autism, Induced Pluripotent Stem Cells | LORING | 728 | 4 | |
119 | Attaining and Maintaining Wellness in OCD | Obsessive-Compulsive Disorder | SIMPSON |
R01MH045436, R01MH045404 |
401, 402 | 133 |
120 | RDoC Constructs: Neural Substrates, Heritability, and Relation to Psychopathology | Research Domain Criteria | ZALD |
R01MH098098
|
500 | 396 |
121 | Depression (RAPID LFMS) | Depression | IOSIFESCU, PAPAKOSTAS, SANACORA |
HHSN2712011000061 |
754, 755, 756, 757, 758, 759 | 90 |
122 | Characterization of a Mendelian Form of Psychosis in a Population Isolate | Schizophrenia | ALMASY, GLAHN, RAVENTOS | 319 | 215 | |
123 | Acute Psychotherapy for Bipolar II Depression | Bipolar Disorder | SWARTZ | 432 | 38 | |
124 | Multi-pronged genetic studies of schizophrenia in an inbred population | Schizophrenia | NIMGAONKAR | 349 | 760 | |
125 | Analysis of Glutamatergic Neurons Derived from Patient Specific iPS Cells | Induced Pluripotent Stem Cells | LACHMAN | 392, 393 | 13 | |
126 | Autism (ACE Network) | Autism | CONSTANTINO, GESCHWIND, KLIN, MOLHOLM |
R01MH100027
|
712, 718, 719, 720 | 1672 |
127 | Target Identification and Validation for Negative Symptoms and Social Cognition in Schizophrenia: A Translational Study | Induced Pluripotent Stem Cells, Schizophrenia | HAHN |
funded by Pfizer via University of Pennsylvania ? Pfizer collaborative alliance |
717 | 8 |
128 | A Comprehensive Approach To Identification of Autism Susceptibility Genes | Autism | GESCHWIND, LAJONCHERE |
R01MH081754
|
713, 714, 715, 716 | 343 |
129 | Anorexia Nervosa Genetics Initiative (ANGI Project) | Eating Disorders | BULIK |
Anorexia Nervosa Genetics Initiative (ANGI Project) |
403, 404 | 5657 |
130 | Genomics-Guided Characterization of iPS Cells from Common Mental Illnesses | Induced Pluripotent Stem Cells | HAGGARTY, PERLIS | 433, 434 | 4 | |
131 | Chemical genomic approaches to neurobiology of DISC1 | Bipolar Disorder, Induced Pluripotent Stem Cells, Schizophrenia | TSAI | 317, 318 | 20 | |
132 | NIMH DIRP Protocol 03-M-0035 Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-Up for Childhood Onset Psychiatric Disorders | Induced Pluripotent Stem Cells | RAPOPORT | 499, 502 | 228 | |
133 | Biomarker Discovery in Anorexia Nervosa II | Eating Disorders | BARDONE-CONE, BULIK | 405 | 169 | |
134 | Genetic Study of Trichotillomania | Obsessive-Compulsive Disorder | KEUTHEN, SCHARF |
Funded by the Trichotillomania Learning Center (TLC). |
508, 788, 790 | 419 |
135 | Multimodal Developmental Neurogenetics of Females with ASD | Autism | BOOKHEIMER, PELPHREY |
R01MH100028
|
470, 471, 472, 473 | 857 |
136 | Integrative Molecular and Phenotype Analysis of 22q11.2 Deletion Syndrome | 22Q11.2DS, Induced Pluripotent Stem Cells, Research Domain Criteria, Schizophrenia | HALLMAYER |
R01MH100900
|
355 | 65 |
137 | Genomics of Schizophrenia in the South African Xhosa (SAXI) | Schizophrenia | KING, STEIN, SUSSER | 356 | 2200 | |
138 | Identification of rare variants of OCD | Obsessive-Compulsive Disorder | NESTADT | 406 | 196 | |
139 | Addition of OCD to the Genomic Psychiatry Cohort | Obsessive-Compulsive Disorder | PATO | 407, 417, 783, 787, 805, 822, 881 | 5000 | |
140 | Genome Sequencing in Extended Bipolar Pedigrees | Bipolar Disorder | FREIMER | 435, 436 | 349 | |
141 | Genetic Analysis of High-Risk Utah Suicide Pedigrees | Suicide | COON | 315 | 3339 | |
142 | Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP) | Research Domain Criteria | CLEMENTZ, KESHAVAN, PEARLSON, TAMMINGA |
R01MH096913-01A1,
R01MH096957-01A1,
R01MH096900-01A1,
R01MH096942-01A1
|
496, 497, 498 | 194 |
143 | Modeling Anorexia Nervosa with Human Pluripotent Stem Cells | Eating Disorders, Induced Pluripotent Stem Cells | MUOTRI | 408 | 8 | |
144 | Modeling Autism with Human Pluripotent Cells | Autism, Induced Pluripotent Stem Cells | MUOTRI | 738 | 17 | |
146 | Induced Neuronal Cells: A Novel Approach to Study Neuropsychiatric Diseases | Autism, Induced Pluripotent Stem Cells | WERNIG | 741 | 8 | |
147 | Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria | Research Domain Criteria | FARAONE, GLATT |
1R01MH101519-01A1
|
501 | 2448 |
148 | Identifying regulatory mutations that influence neuropsychiatric disease | Schizophrenia | GOLDSTEIN, PULVER | 357, 358, 359 | 340 | |
149 | Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID) | Depression | CUSIN, FAVA, IOSIFESCU, SANACORA |
HHSN271201100006I
|
760, 761, 762, 763, 764, 765 | 100 |
150 | The Genomics of Treatment-Resistant Psychotic Symptoms | Schizophrenia | EVANS, FARRELL, JOSIASSEN, SHAUGHNESSY, SULLIVAN |
none |
354 | 1000 |
151 | Predictors and Mechanisms of Conversion to Psychosis (NAPLS3) | Research Domain Criteria, Schizophrenia | ADDINGTON, CANNON, CORNBLATT, MATHALON |
2R01MH081902-06A1
|
486, 487, 488, 489, 490, 491, 492, 493, 494 | 711 |
152 | Control and Reward Circuits as Targets for Repetitive Thoughts and Behaviors | Obsessive-Compulsive Disorder | MARSH | 409 | 66 | |
154 | FAST MAS KOR Phase 2a | Research Domain Criteria | LISANBY, NURNBERGER, SANACORA |
HHSN2712011000061
|
410, 411, 412, 413, 414, 415 | 78 |
155 | Gene Networks Influencing Psychotic Dysconnectivity in African Americans | Schizophrenia | GLAHN | 360 | 750 | |
156 | Transferred from Coriell Collection | Bipolar Disorder, Schizophrenia | GERSHON |
|
735, 736 | 2000 |
157 | Neuroinflammation and Aggression (RDoC) | Research Domain Criteria | COCCARO | 503 | 150 | |
158 | Modeling schizophrenia using iPSC neurons | Induced Pluripotent Stem Cells | BRENNAND |
Supported by private funds |
361 | 11 |
159 | A chimeric brain model to study human neurological diseases | Autism, Induced Pluripotent Stem Cells | MUOTRI | 742 | 6 | |
160 | Contrasting causal microRNAs in forebrain and midbrain COS hiPSC neural cells | Induced Pluripotent Stem Cells | BRENNAND | 504 | 22 | |
161 | iPSC-derived human cortical interneurons as developmental model of Schizophrenia | Induced Pluripotent Stem Cells, Schizophrenia | CHUNG | 362, 363, 807 | 6 | |
162 | Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP2) | Bipolar Disorder, Schizophrenia | TAMMINGA |
2R01MH077851-05A1
|
364, 365, 366, 367, 368 | 3600 |
163 | Neuropsychiatric Genome-Scale and RDoC Individualized Domains (N-GRID) | Induced Pluripotent Stem Cells | KOHANE, PERLIS | 416 | 134 | |
164 | The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) | Autism | MCPARTLAND |
1U19MH108206-01
|
474, 475, 476, 477, 478 | 531 |
165 | Neural development of human induced pluripotent stem cells from schizophrenia patients | Induced Pluripotent Stem Cells, Schizophrenia | SONG |
R21/R33MH087874 |
369 | 4 |
166 | Juvenile Onset Schizophrenia iPSCs | Induced Pluripotent Stem Cells, Schizophrenia | FINDLING, MILLER, TESAR | 370 | 13 | |
167 | Biomarker Assessment of Pomaglumetad on Glutamate Targets: Proof of Clinical Mechanism of Action (POCM) | Controls | LIEBERMAN |
HHSN271201200007I,
HHSN27100003
|
793, 794, 795, 796 | 91 |
168 | Mapping the Human Connectome During Typical Aging | Brain Function | ANCES, BOOKHEIMER, SALAT, TERPSTRA, VAN ESSEN |
U01 AG052564
|
797, 798, 799, 800 | 1223 |
169 | Genomics of Postpartum Depression. | Depression | MELTZER-BRODY, SULLIVAN |
There is no grant number for this study |
669, 769 | 25000 |
171 | Genetic Contributions of Negative Valence Systems to Internalizing Pathways | Research Domain Criteria | ROBERSON-NAY |
R01MH101518
|
771 | 307 |
172 | A Clinical Study to Establish a Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood | Autism | BURRIER |
1R44MH107124-01
|
772, 773, 774, 775, 776, 777, 784, 786 | 367 |
174 | The Role of Dysmyelination in Cognitive Impairment of Psychotic Disorders | Schizophrenia | LAZAR |
1R01MH108962-01
|
779 | 210 |
175 | Neurobiology of Autism With Macrocephaly | Autism, Induced Pluripotent Stem Cells | VACCARINO |
R01MH109648
|
780 | 62 |
178 | Human Connectome Project for Early Psychosis; Human Connectome Project for Early Psychosis iPSC bank. | Brain Function | BREIER, SHENTON |
U01MH109977; NHMRC Investigator Grant APP1175754
|
1031, 791, 792 | 205 |
179 | Ultra High Field Strength MRI and MRS Study of Bipolar Disorder in Adolescents | Bipolar Disorder | BLUMBERG | 789 | 52 | |
180 | Mapping the Human Connectome During Typical Development | Brain Function | BARCH, BOOKHEIMER, SOMERVILLE, THOMAS, VAN ESSEN |
U01MH109589
|
801, 802, 803, 804 | 1243 |
181 | Development of New therapeutic targets for patients with Bipolar disorder who are resistant to conventional psychotropic medications using induced Pluripotent Stem Cells (iPSC) | Bipolar Disorder, Induced Pluripotent Stem Cells | CHUNG, GAGE |
There is no grant number associated with this study |
806 | 20 |
182 | Systematic Functional Interpretation of Regulatory Variants in Schizophrenia | Induced Pluripotent Stem Cells, Schizophrenia | DUAN, PENZES | 808, 809, 836 | 20 | |
183 | Multimodal analysis of high-risk psychosis mutations in induced neuronal cells | Induced Pluripotent Stem Cells, Schizophrenia | LEVINSON, SUDHOF, WERNIG | 810, 811 | 20 | |
184 | iPSC-based platform development for major psychiatric disorder modeling and discovery | Bipolar Disorder, Induced Pluripotent Stem Cells | ALDA, BANG, CHEN, GAGE, MCINNIS, OSHEA, SONG |
U19MH106434
|
812, 813 | 58 |
185 | Alzheimer?s Disease Connectome Project | Alzheimer's Disease, Brain Function | BENDLIN, LI | 814, 815 | 300 | |
187 | Healthy Brain Network | Brain Function | MILHAM |
Not associated with an active grant |
818 | 6500 |
188 | Aging and Emotion Regulation Brain Circuitry in Bipolar Disorder | Bipolar Disorder | BLUMBERG |
R01MH113230
|
819 | 160 |
189 | Genetics of Severe Mental Illness -Colombia | Schizophrenia | BEARDEN, FREIMER, LOPEZ-JARAMILLO |
R01MH113078
|
820 | 10000 |
190 | MicroRNA Dysregulation in Psychiatric Disorders and Cognitive Dysfunction. | Induced Pluripotent Stem Cells, Schizophrenia | GOGOS, MARKX |
R01MH097879
|
821 | 12 |
191 | Longitudinal Assessment of Posttraumatic Syndromes. | Research Domain Criteria | JOVANOVIC, KESSLER, KOENEN, MCLEAN, PALLIN, PEARSON, SERGOT |
U01MH110925
|
823, 824, 825, 826, 827, 828, 829, 830, 831, 832, 833, 841, 842, 843, 846, 847, 865, 866, 867, 872, 873, 874, 875, 876, 877, 878, 879, 880 | 3900 |
192 | Modeling the Human Neuronal Phenotype of the Schizophrenia-Associated 3q29 Deletion | Induced Pluripotent Stem Cells, Schizophrenia | MULLE |
R01MH110701
|
834 | 90 |
193 | Binge Eating Genetics INitiative (BEGIN) | Eating Disorders | BULIK |
na
|
835 | 5000 |
194 | Dimensional Connectomics of Anxious Misery | Fear & Anxiety | SHELINE |
U01MH109991
|
837 | 250 |
195 | Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia | Induced Pluripotent Stem Cells, Schizophrenia | BRENNAND, BUXBAUM |
R01MH111679
|
838 | 111 |
196 | Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies. | Controls | CHUNG |
n/a (Protocol number 17-M-0181)
|
839 | 2000 |
197 | A conserved transcriptional cascade involved in brain overgrowth, social behavior and autism. | Autism, Induced Pluripotent Stem Cells | WYNSHAW-BORIS | 840 | 12 | |
199 | The GEN-SCRIP Study (GENetics of SChizophRenia in Pakistan) | Schizophrenia | KNOWLES | 854 | 17000 | |
200 | Mechanisms of Circuit Failure and Treatments in Patient-derived Neurons in Autism | Autism, Induced Pluripotent Stem Cells | MORROW | 857 | 15 | |
201 | Cellular, molecular, and functional imaging approaches to understanding early neurodevelopment in autism. Project 3: Biological substrates of risk and resilience using patient-derived stem cells | Autism, Induced Pluripotent Stem Cells | VACCARINO |
P50MH115716
|
858 | 33 |
202 | Genetic Characterization of Neurodevelopmental Disorders in African Populations (NeuroDev Africa) | Brain Function | ABUBAKAR, DONALD, ROBINSON |
R01HD102975-01 |
859 | 6000 |
203 | Collaborative Genomic Studies of Tourette Disorder: Phase II | Induced Pluripotent Stem Cells, Tourette Syndrome | BROWN, COFFEY, GILBERT, HEIMAN, HUYSER, KUPERMAN, WILLSEY, ZINNER |
R01MH115958; R01MH115959; R01MH115960; R01MH115961; R01MH115962; R01MH115963; R01MH115993
|
600, 601, 602, 603, 604, 606, 608, 610, 611, 612, 614, 615, 616, 620, 861, 862, 863, 864, 883, 890, 968, 997 | 3000 |
204 | Autism Genetics, Phase II: Increasing Representation of Human Diversity | Autism | GESCHWIND |
R01MH100027-11
|
712, 718, 719, 720 | 1691 |
205 | Hoarding disorder in older adults: cognition, etiology and functional impact. | Obsessive-Compulsive Disorder | MACKIN, MATHEWS |
R01MH117114
|
870, 871 | 3500 |
210 | Dissecting the effects of genomic variants on Neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders. | Rare Genetic Syndromes | GUR |
U01MH119738-01; U01MH119737-01; U01MH119736-01; U01MH119758-01; U01MH119741-01; U01MH119739-01
|
884, 885, 886, 887, 888, 896 | 2000 |
212 | Multimodal Developmental Neurogenetics of Females with ASD | Autism | PELPHREY |
MH100028
|
891, 892, 894, 895 | 400 |
213 | Leveraging Rare Genetic Etiologies to Advance Knowledge and Treatment of Neuropsychiatric Disorders | Rare Genetic Syndromes | MARTIN |
U01 MH119705
|
898, 899 | 1233 |
214 | Genetics of suicide death | Suicide | COON |
R01MH122412
|
315 | 3500 |
215 | Eating Disorder Genetics Initiative (EDGI) | Eating Disorders | BULIK |
R01MH120170
|
900, 901, 902 | 11000 |
216 | Latino Ancestry Genomic Psychiatry Cohort | Bipolar Disorder, Controls, Schizophrenia | BIGDELI, FANOUS, PATO |
R01MH123451
|
903, 904, 918, 919 | 6000 |
217 | African Ancestry Genomic Psychiatry Cohort - Phase II and Populations Underrepresented in Mental illness Association Studies (PUMAS) | Bipolar Disorder, Controls, Schizophrenia | BIGDELI, FANOUS, PATO | 1018, 352, 844, 869, 920 | 4000 | |
218 | The GEN-BLIP Study (GENetics of BipoLar Disorder In Pakistan) | Bipolar Disorder | KNOWLES |
1R01MH123775-01
|
905 | 12000 |
219 | Powering Genetic Discovery for Severe Mental Illness in Latin American and African Ancestries. | Bipolar Disorder, Controls, Schizophrenia | FREIMER, LOPEZ-JARAMILLO, OLDE LOOHUIS, OPHOFF |
U01MH125042
|
1000, 906, 907, 908, 909, 998, 999 | 18900 |
221 | Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations | Brain Function | BUCKLEY, FARMER, PAO, THURM |
N/A. This study is supported via intramural funding.
|
913 | 244 |
222 | ProNET: Psychosis-Risk Outcomes Network | Research Domain Criteria, Schizophrenia | BEARDEN, KANE, WOODS |
U01MH124639
|
1032, 1033, 1034, 1035, 1036, 1037, 1038, 1039, 1040, 1041, 1042, 1043, 1044, 1045, 1046, 1047, 1048, 1049, 1050, 1051, 1052, 1053, 1054, 1055, 1056, 1057, 914 | 1430 |
223 | Trans-ancestry genomic analysis of obsessive-compulsive disorder | Obsessive-Compulsive Disorder | CROWLEY, IRRENO SOTOMONTE , STORCH |
U01MH125062 and U01MH125050
|
1001, 1002, 1003, 1004, 1005, 1006, 1007, 1010, 1014, 1017, 1028, 1029, 916, 922, 923, 924, 925, 927, 928, 933, 934, 938, 944, 945, 947, 948, 949, 950, 952, 953, 955, 958, 959, 960, 966, 976, 977, 995 | 5000 |
224 | The Price Foundation Genetic Studies of Anorexia and Bulimia Nervosa. | Eating Disorders | KAYE |
Price Foundation |
921, 973, 974 | 3741 |
225 | Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Confirmation Study and Pre-School Feasibility Study | Autism | MCPARTLAND |
2U19MH108206-05
|
969, 970, 971, 972, 975 | 675 |
226 | MRI Based Presymptomatic Prediction of ASD | Autism | PIVEN, PRUETT |
1R01MH118362-01
|
978, 979, 980, 981, 982 | 1000 |
227 | Breaking Through In OCD Genetics | Induced Pluripotent Stem Cells, Obsessive-Compulsive Disorder | STATE, WILLSEY |
Foundation for OCD Research Grant #: 009395-2019-10-02 |
1019, 1020, 983, 984, 985, 986, 987, 988, 989, 990, 991, 992 | 5000 |
228 | Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome | Autism, Induced Pluripotent Stem Cells | LACHMAN |
R01MH131740
|
1021 | 16 |
229 | Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model | Autism, Induced Pluripotent Stem Cells | MUOTRI |
1R01MH123828-01A1 |
1022 | 12 |
230 | Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism | Autism, Induced Pluripotent Stem Cells | GOREN, MUOTRI |
R01MH127077 |
1023 | 6 |
231 | Uncovering sex-specific differences in ASH1L-disease | Autism, Induced Pluripotent Stem Cells | LIU, LIZARRAGA |
R21MH136643
|
1027 | 10 |
232 | Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort | Induced Pluripotent Stem Cells, Schizophrenia | HART, MULLE, PANG, PATO |
R01MH131296
|
1024 | 0 |
233 | Neurodevelopment of Tourette syndrome | Induced Pluripotent Stem Cells, Tourette Syndrome | VACCARINO |
1R01MH118453-01
|
1025 | 30 |
234 | IBIS-iPSC: Organoid modeling of cortical surface area hyperexpansion in autism spectrum disorder | Autism, Induced Pluripotent Stem Cells | STEIN |
1R01MH130441-01A1
|
1026 | 99 |
238 | Genetic Architecture of Early-Onset Psychosis in Mexicans (EPIMex2) | Bipolar Disorder, Schizophrenia | ALMASY, GLAHN, NICOLINI |
1R01MH133621-01
|
1030 | 5000 |
239 | Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis | CADENHEAD |
R01MH123641
|
1058, 1059, 1060, 1061, 1062, 1063, 1064, 1065, 1066 | 250 | |
Study | Title | Distributions | PIs | Grants | Sites | Subjects |